REFERENCES
- Dunlap J.C. Molecular bases for circadian clocks. Cell 1999; 96: 271–290
- Field M.D., Maywood E.C., O'Brien J.A., Weaver D.R., Reppert S.M., Hastings M.H. Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms. Neuron 2000; 25: 437–447
- Redfern P.H., Lemmer B. Physiology and Pharmacology of Biological Rhythms. Springer, Berlin 1997; Vol. 125
- Hrushesky W.J., Bjarnason G.A. Circadian cancer therapy. J. Clin. Oncol. 1993; 11: 1403–1417
- Focan C. Circadian rhythms and cancer chemotherapy. Pharmacol. Ther. 1995; 67: 1–52
- Lévi F. Chronopharmacology of anticancer agents. Physiology and Pharmacology of Biological Rhythms, P.H. Redfern, B. Lemmer. Springer, Berlin 1997; 299–331
- Lévi F. Cancer chronotherapy. Lancet Oncol. 2001; 2: 307–315
- Li Zeng-cun. The epidemiology of nasopharyngeal carcinoma. Nasopharyngeal Carcinoma, Clinical and Laboratory Research, Zeng-cun Li, Qi-chao Pan, Jian-jin Chen. Scientific Technique Publishing House, Guangdong, China 1983; 1–68
- Li Zeng-cun, Yu Mimic, Henderson B.E. Some epidemiological observation of nasopharyngeal carcinoma in Guangdong, China. Chinese J. Cancer 1985; 4: 187–191
- Qian C.N., Zhang C.Q., Guo X., Hong M.H., Cao S.M., Mai W.Y., Min H.Q., Zeng Y.X. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer 2000; 88(2)255–261
- Gu S.Y., Tang W.P., Li K., Zhao W.P., Zhao M.L., Zeng Y., Deng H.P. An epithelial cell line established from poorly differentiated nasopharyngeal carcinoma. Chinese J. Cancer 1983; 2: 70–72
- Klein D.C., Moore R.Y., Reppert S.M. Suprachiasmatic Nucleus, the Mind'Clock. Oxford University Press, Oxford 1991
- Touitou Y., Haus E. Biological Rhythms in Clinical and Laboratory Medicine. Springer, Berlin 1992
- Klevecz R., Shymko R., Blumenfeld D., Braly P. Circadian gating of S phase in human ovarian cancer. Cancer Res. 1987; 47: 6267–6271
- Smaaland R., Lote K., Sothern R.B., Laerum O.D. DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate variation depending on circadian stage of cell sampling. Cancer Res. 1993; 53: 3129–3138
- Hrushesky W.J., Lannin D., Haus E. Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J. Natl. Cancer Inst. 1998; 90: 1480–1484
- Mormont M.C., Lévi F. Circadian system alterations during cancer processes: a review. Int. J. Cancer 1997; 70: 241–247
- Jiang W.Q., Lu Z.H., He Y.J., Diasio R.B. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin. Cancer Res. 1997; 3: 395–399
- Peters G.J., Van Dijk J., Nadal J.C., Van Groeningen C.J., Lankelma J., Pinedo H.M. Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer. In Vivo 1987; 1: 113–118
- Kojima H., Sakamoto J., Yasue M. Circadian rhythm-modulated chemotherapy with high dose 5-fluorouracil against gastrointestinal cancers: evaluation and case report. Nagoya J. Med. Sci. 1999; 62: 29–38